These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2276680)

  • 1. Erythropoietin: biological aspects and clinical usefulness.
    Liberato NL; Costa A; Barosi G
    Haematologica; 1990; 75(4):346-62. PubMed ID: 2276680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human erythropoietin. Experimental and clinical applications.
    Nielsen OJ
    Dan Med Bull; 1991 Oct; 38(5):355-70. PubMed ID: 1802621
    [No Abstract]   [Full Text] [Related]  

  • 3. [Erythropoietin: its biological properties and clinical use].
    Ermolenko VM; Nikolaev AIu
    Ter Arkh; 1990; 62(11):141-5. PubMed ID: 2094979
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythropoietin: from molecular biology to clinical use.
    Lacombe C
    Eur Cytokine Netw; 1997 Sep; 8(3):308-10. PubMed ID: 9346370
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of chronic renal failure on the expression of erythropoietin message in a murine model.
    Zhang F; Laneuville P; Gagnon RF; Morin B; Brox AG
    Exp Hematol; 1996 Nov; 24(13):1469-74. PubMed ID: 8950229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Erythropoietin: from gene to therapeutic agent].
    Bauer C
    Schweiz Rundsch Med Prax; 1994 Jun; 83(23):698-701. PubMed ID: 8016510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological characterization of recombinant human erythropoietin.
    Krumwieh D; Arnold I; Seiler FR
    Behring Inst Mitt; 1988 Aug; (83):193-201. PubMed ID: 3240225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Erythropoietin in 1991--pathophysiological and therapeutic aspects].
    Wiecek A
    Przegl Lek; 1992; 49(1-2):31-5. PubMed ID: 1455002
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure].
    Arenas Gracia M; Abad Gosálvez A; Colomina Avilés J; Pascual Pérez R; Ferriz Moreno P
    An Med Interna; 1995 Apr; 12(4):187-8. PubMed ID: 7620064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin: biology and clinical use.
    Graber SE; Krantz SB
    Hematol Oncol Clin North Am; 1989 Sep; 3(3):369-400. PubMed ID: 2561121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure.
    Erslev AJ; Besarab A
    Kidney Int; 1997 Mar; 51(3):622-30. PubMed ID: 9067892
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythropoietin.
    Erslev AJ
    Leuk Res; 1990; 14(8):683-8. PubMed ID: 2201820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical application of erythropoietin.
    Urabe A; Kitamura T; Takaku F
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1355-9. PubMed ID: 3073611
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythropoietin: its role in the regulation of erythropoiesis and as a therapeutic in humans.
    Adamson JW
    Biotechnology; 1991; 19():351-63. PubMed ID: 1786475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biological similarity of erythropoietin: controlled maturation].
    Combe C
    Nephrol Ther; 2009 Feb; 5 Spec No1():1-2. PubMed ID: 19233074
    [No Abstract]   [Full Text] [Related]  

  • 16. Dose-related effects of recombinant human erythropoietin on erythropoiesis. Results of a multicenter trial in patients with end-stage renal disease.
    Bommer J; Kugel M; Schoeppe W; Brunkhorst R; Samtleben W; Bramsiepe P; Scigalla P
    Contrib Nephrol; 1988; 66():85-93. PubMed ID: 3292151
    [No Abstract]   [Full Text] [Related]  

  • 17. Erythropoietin: in vitro and in vivo studies of the regulation of erythropoiesis.
    Adamson JW
    Schweiz Med Wochenschr; 1988 Oct; 118(42):1501-6. PubMed ID: 2849202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic kidney failure, anemia and erythropoietin].
    Sulková S
    Cas Lek Cesk; 1990 May; 129(18):545-9. PubMed ID: 2350772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of initial resistance of erythropoiesis to treatment with recombinant human erythropoietin. Results of a multicenter trial in patients with end-stage renal disease.
    Kühn K; Nonnast-Daniel B; Grützmacher P; Grüner J; Pfåffl W; Baldamus CA; Scigalla P
    Contrib Nephrol; 1988; 66():94-103. PubMed ID: 3292152
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of the anaemia of chronic renal failure with recombinant erythropoietin.
    Adamson JW; Eschbach JW
    Q J Med; 1989 Dec; 73(272):1093-101. PubMed ID: 2694210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.